Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Hyloris Pharmaceuticals (0AB6)

Hyloris Pharmaceuticals Sa
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0AB6
DateTimeSourceHeadlineSymbolCompany
14/03/202406:00UK RegulatoryHyloris Présente ses Résultats Annuels pour 2023 et ses PerspectivesLSE:0AB6Hyloris Pharmaceuticals Sa
14/03/202406:00UK RegulatoryHyloris Reports Full Year Results for 2023 & Provides Business OutlookLSE:0AB6Hyloris Pharmaceuticals Sa
14/03/202405:59UK RegulatoryCommunication at the request of the FSMA on the transactions with QliniqLSE:0AB6Hyloris Pharmaceuticals Sa
14/03/202405:59UK RegulatoryCommuniqué à la requête de la FSMA sur les transactions avec QliniQLSE:0AB6Hyloris Pharmaceuticals Sa
08/03/202406:00UK RegulatoryHyloris to Report 2023 Full-Year Results on 14 March 2024LSE:0AB6Hyloris Pharmaceuticals Sa
08/03/202406:00UK RegulatoryHyloris Annonce ses Résultats Financiers Annuels le 14 mars 2024LSE:0AB6Hyloris Pharmaceuticals Sa
27/02/202417:00UK RegulatoryHyloris Annonce le Lancement de Maxigesic® IV aux Etats-Unis ainsi que son Approbation au CanadaLSE:0AB6Hyloris Pharmaceuticals Sa
27/02/202417:00UK RegulatoryHyloris Announces Launch of Maxigesic® IV in the U.S. and approval In CanadaLSE:0AB6Hyloris Pharmaceuticals Sa
14/02/202417:00UK RegulatoryHyloris Recrute un Premier Patient dans le Cadre d'un Essai Clinique de Phase 3 portant sur son Rince-Bouche Breveté Destiné à Contrôler les Saignements lors des Interventions DentairesLSE:0AB6Hyloris Pharmaceuticals Sa
14/02/202417:00UK RegulatoryHyloris Enrolls First Patient in Phase 3 Clinical Trial for its Proprietary Mouth Rinse to Control Incidences of Bleeding Related to Dental ProceduresLSE:0AB6Hyloris Pharmaceuticals Sa
30/01/202406:00UK RegulatoryHyloris et Purna Female Healthcare Annoncent des Résultats Positifs de leur Essai Clinique de Phase 2 chez des Patientes atteintes de Candidose Vulvovaginale Aiguë (CVV)LSE:0AB6Hyloris Pharmaceuticals Sa
30/01/202406:00UK RegulatoryHyloris and Purna Female Healthcare Announce Positive Results from Phase 2 Trial in Patients with Acute Vulvovaginal Candidiasis (VVC)LSE:0AB6Hyloris Pharmaceuticals Sa
 Showing the most relevant articles for your search:LSE:0AB6